Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Genscript Biotech ( (HK:1548) ) has shared an announcement.
Genscript Biotech Corporation announced that its associate, Legend Biotech Corporation, has released its financial results for the second quarter of 2025. The results, filed with the SEC, highlight Legend Biotech’s recent business achievements. Shareholders are advised to consider investment risks when dealing with Genscript’s securities.
More about Genscript Biotech
Genscript Biotech Corporation, incorporated in the Cayman Islands, operates in the biotech industry. The company is involved in the development and commercialization of innovative biotechnological products and services, with a focus on advancing healthcare solutions globally.
YTD Price Performance: 72.26%
Average Trading Volume: 29,301,189
Technical Sentiment Signal: Buy
Current Market Cap: HK$36.78B
For a thorough assessment of 1548 stock, go to TipRanks’ Stock Analysis page.